Literature DB >> 20870406

Pattern of care in locally advanced breast cancer: focus on local therapy.

Marcin Sinacki1, Andrzej Badzio, Marzena Wełnicka-Jaśkiewicz, Jan Bogaerts, Martine J Piccart, Patrick Therasse, Ian E Smith, Thomas Hatschek, Jacek Jassem.   

Abstract

BACKGROUND AND METHODS: The optimal treatment of locally advanced breast cancer (LABC) remains undetermined. We analyzed factors influencing local therapy in LABC in a pooled material including three large clinical series.
RESULTS: Of a total of 787 patients, local therapy was given in 604, surgery in 184, radiotherapy in 69, and a combination thereof in 351. The use of local therapy was related to younger age, lower clinical T and N stage, no skin involvement and no progression during induction chemotherapy. The use of surgery was related to younger age, lower clinical T and N stage, no clinical skin involvement and response to induction chemotherapy. The use of postoperative radiotherapy was correlated with larger tumor size, higher number of positive lymph nodes, positive surgical margin, extracapsular lymph node extension, lymphatic vessel invasion and skin involvement.
CONCLUSIONS: The most frequent local therapy in LABC remains a combination of surgery and radiotherapy. Clinical and pathological characteristics influence the type of local treatment.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20870406     DOI: 10.1016/j.breast.2010.08.008

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  6 in total

1.  Application of a rhomboid flap for the coverage of defects after malignant breast tumor resection: A case report.

Authors:  Kazuyuki Kubo; Hiroyuki Takei; Hiroshi Matsumoto; Atsumori Hamahata
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

2.  Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.

Authors:  J Xu; C Ni; C Ma; L Zhang; X Jing; C Li; Y Liu; X Qu
Journal:  Clin Transl Oncol       Date:  2017-02-28       Impact factor: 3.405

3.  Regression in local recurrence in the contralateral breast following mastectomy in bilateral locally advanced breast cancer: A comparison of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios.

Authors:  Abdullah Durhan; Gamze Durhan; Aydan Eroğlu
Journal:  Turk J Surg       Date:  2018-01-03

4.  ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Authors:  F Cardoso; A Costa; L Norton; E Senkus; M Aapro; F André; C H Barrios; J Bergh; L Biganzoli; K L Blackwell; M J Cardoso; T Cufer; N El Saghir; L Fallowfield; D Fenech; P Francis; K Gelmon; S H Giordano; J Gligorov; A Goldhirsch; N Harbeck; N Houssami; C Hudis; B Kaufman; I Krop; S Kyriakides; U N Lin; M Mayer; S D Merjaver; E B Nordström; O Pagani; A Partridge; F Penault-Llorca; M J Piccart; H Rugo; G Sledge; C Thomssen; L Van't Veer; D Vorobiof; C Vrieling; N West; B Xu; E Winer
Journal:  Ann Oncol       Date:  2014-09-18       Impact factor: 32.976

5.  Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.

Authors:  Li Chen; Xiangyi Kong; Zhongzhao Wang; Xiangyu Wang; Yi Fang; Jing Wang
Journal:  J Cell Mol Med       Date:  2020-01-27       Impact factor: 5.310

6.  Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Authors:  Cong Jiang; Yubo Lu; Shiyuan Zhang; Yuanxi Huang
Journal:  Biomed Res Int       Date:  2020-12-18       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.